BofA Securities Downgrades Sage Therapeutics (SAGE) to Neutral

August 7, 2023 12:56 PM

BofA Securities analyst Tazeen Ahmad downgraded Sage Therapeutics (NASDAQ: SAGE) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found